Drug intelligence / Profile preview

siCOX7A1

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

siCOX7A1 is a small interfering RNA (siRNA) designed to silence the expression of the Cytochrome c oxidase subunit 7A1 (COX7A1) gene. In the context of endometrial cancer research, COX7A1 has been identified as a driver of ferroptosis—a form of regulated cell death characterized by iron-dependent lipid peroxidation. While COX7A1 overexpression induces mitochondrial dysfunction and ferroptosis, the use of siCOX7A1 to knock down this gene has been shown to inhibit ferroptosis and promote the proliferation of endometrial cancer cells. This tool is primarily used in preclinical research to investigate the molecular mechanisms of mitochondrial function and iron metabolism in cancer.

Other names
COX7A1 siRNACOX-7A1 siRNACOX 7A1 siRNAsmall interfering RNA targeting COX7A1
02

Targets

COX7A1 (Cytochrome C Oxidase)

Beyond the preview

Go deeper on siCOX7A1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siCOX7A1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call